DONATE

Josep Samitier

Group leader

Researchers identify new biomarkers of the most frequent lung cancer

From left to right: Marselina Arshakyan (co-first author of the study), Rafael Ikemori, Paula Duch, Jordi Alcaraz and Marta Gabasa.

Researchers from the IBEC and the University of Barcelona (UB) have identified new biomarkers for non-small cell lung cancer, the most common lung cancer. The results, published in the journal Modern Pathology, were obtained thanks to a new technique that allows quantitative analysis of patient samples. It is a pioneering methodology that is cheaper and easier … Read more

Daniel Navajas: 30 years dedicated to mechanobiology

Last May 5, on the occasion of Professor Daniel Navajas’ retirement, the IBEC held the symposium Before Mechanobiology had a name. The event paid tribute to the IBEC researcher’s exciting career over three decades, focusing on mechanobiology and cellular biophysics current research. Professor Daniel Navajas stands out as a pioneer in the field of mechanobiology … Read more

Researchers developed a chip to simulate the blood-brain barrier in the brain

A study led by IBEC researchers has made it possible to reproduce the blood-brain barrier using the organ-on-a-chip (OoC) platform with the ultimate goal of being able to study the permeability of this membrane to different Alzheimer’s drugs. This type of chip will also make it possible to screen for the most effective drugs, avoiding … Read more

Nanomedicine experts meet to tackle rare diseases

Yesterday, experts in Nanomedicine from different fields gathered for the fourth consecutive year at the Nano Rare Diseases Day. This event is co-organized by the NANOMED Spain platform, coordinated by IBEC, and SJD Barcelona Children’s Hospital, where the latest advances in nanomedicine for diagnosing and treating rare diseases are exposed.  Yesterday, February 28, took place … Read more

Challenges and opportunities in biomedical research

The 15th Annual Conference of Biomedical Research Technology Platforms was held yesterday and, with more than 700 participants, it has become the reference forum for analyzing the main challenges and opportunities facing Spain in biomedical research. The event, which was attended by Josep Samitier, director of the Institute for Bioengineering of Catalonia (IBEC) and scientific coordinator of the Nanomed Spain platform, brought together representatives of the Administration, regulatory agencies, universities and companies, as well as clinical researchers and patients.